Total deal volume in the medical device industry contracted by about 13% in 2013, according to new analysis from audit shop PricewaterhouseCoopers.
Medtech M&A analysis: 41 device companies sold in 2013
Vital Images, Toshiba land close to $200M in DoD deals
Vital Images and Toshiba Medical Systems’ (TYO:6502) American division secured a combined $198 million in separate supply deals with the U.S. Dept. of Defense.
Abbott, St. Jude Medical re-up ‘cardiovascular alliance’ | Wall Street Beat
Medtronic lands EU approval for CoreValve | Regulatory Roundup
Medtronic Inc. (NYSE:MDT) won CE Mark approval in the European for its percutaneous aortic valve replacement system, CoreValve.
The device is "the only transcatheter aortic valve available in the world that can treat – without surgery – patients with larger valve openings (up to 29mm)," according to a press release.
CoreValve is the largest transcatheter valve available, but can compress into a small delivery system to be deployed in the same delivery system as smaller CoreValve sizes.
iCAD and Vital Images team up on colonoscopy imaging
Toshiba Medical completes tender offer for Vital Images
Toshiba Medical Systems Corp. successfully completed its tender offer for the $273 million acquisition of Vital Images Inc. (NSDQ:VTAL).
At the end of the second offering period 12,253,984 shares were validly tendered, representing about 86.7 percent of Vital Image’s outstanding stock on a non-fully diluted basis and about 76.8 percent of the stock on a fully diluted basis.
Toshiba takes one step closer to $273 Vital Images acquisition | Acquisitions roundup
Toshiba Medical Systems Corp. came one step closer the $273 million acquisition of Vital Images Inc. (NSDQ:VTAL) with the announcement that the initial tender offer period had expired.
A total of 11.9 million shares were tendered by expiration time, representing about 72 percent of Vital Images’ outstanding common stock on a fully diluted basis.
Vital Images’ Q4 losses widen 63 percent
Vital Images Inc. (NSDQ:VTAL) posted fourth-quarter sales of $6.6 million for the three months ended Dec. 31, 2009, down 18.8 percent compared with $8.1 million during the same period in 2008. Net losses widened 63.2 percent to $630,000, compared with $386,000 during Q4 2008:
